Christopher Keenan | VP of IR |
Sean McCarthy | President, CEO |
Robin Knifsend | VP of Finance |
Amy Peterson | Chief Development Officer |
Varun Kumar | Cantor Fitzgerald |
Mohit Bansal | Citi |
Mara Goldstein | Mizuho Securities |
Boris Peaker | Cowen & Company |
Biren Amin | Jefferies |
Terence Flynn | Goldman Sachs |
Robert Burns | H.C. Wainwright |
Good day, ladies and gentlemen, and welcome to the CytomX Therapeutics Third Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
As a reminder, this call may be recorded.
I would now like to introduce your host for today's conference, Christopher Keenan, Vice President of Investor Relations. Chris, you may begin.